Keywords: pathogenesis, gains, uk, approval, tobi, says, received

PathoGenesis gains UK approval for TOBI

Article | 21 December 1999

Print This

PathoGenesis says it has received approval from the UK MedicinesControl Agency for TOBI 300mg/ 5mL nebulizer solution (tobramycin) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in